ArticleScientific reports2023

Efficacy of second-line chemotherapy after treatment with gemcitabine plus nab-paclitaxel or FOLFIRINOX in patients with metastatic pancreatic cancer.

Masaru Fukahori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.